Tramadol (Ultram): Dependence, Withdrawal, and Recovery Support

Tramadol (Ultram) is an opioid. That surprises a lot of people, because for almost twenty years it was sold in the United States as an unscheduled pain reliever and often described as the "safe" alternative to hydrocodone. The DEA placed it in Schedule IV of the Controlled Substances Act effective August 18, 2014 (Federal Register, 2014), and its label now carries the same boxed warning on addiction, abuse, misuse, and life-threatening respiratory depression as every other prescription opioid (Ultram prescribing information, 2023). Tramadol also acts on serotonin and norepinephrine, which changes how withdrawal feels. This page covers dependence, withdrawal, treatment, and how ongoing support at home fits once the medical part is handled.

What tramadol is and how it works

Tramadol is a synthetic opioid approved for "the management of pain in adults that is severe enough to require an opioid analgesic and for which alternative treatments are inadequate" (prescribing information, section 1). It is sold as Ultram, Ultram ER, ConZip, Qdolo, and generic tramadol hydrochloride, and combined with acetaminophen as Ultracet. On the street it goes by "trammies," "ultras," or "chill pills." Pills bought online or from a friend can be anything; DEA testing finds that 5 out of every 10 counterfeit pills with fentanyl hold a potentially lethal dose (DEA).

The label describes the pain relief as coming from "both binding to µ-opioid receptors and weak inhibition of re-uptake of norepinephrine and serotonin" (section 12.1). Half of it works like a weak opioid and half a little like an antidepressant, which is why members tell us they kept taking it long after the back pain resolved: they felt flat without it.

Two more facts matter. First, the drug is short-acting: the mean elimination half-lives of tramadol and its active metabolite M1 are about 6.3 and 7.4 hours (prescribing information, section 12.3), so a dependent person feels it wearing off the same day. Second, the opioid effect depends on your genes. The liver enzyme CYP2D6 converts tramadol into its stronger metabolite, and "ultra-rapid metabolizers" get a much larger opioid dose than expected, a phenotype the label estimates at "1 to 10% for Whites (European, North American)" and higher in some other groups (section 5). It is why tramadol "is contraindicated in children younger than 12 years of age," and why two adults on the same 50 mg tablet can have very different experiences.

Dependence, misuse, and addiction are not the same thing

The label defines the first: "Physical dependence is a physiological state in which the body adapts to the drug after a period of regular exposure, resulting in withdrawal symptoms after abrupt discontinuation or a significant dosage reduction of a drug" (section 9.3). Dependence happens to people who take tramadol exactly as prescribed for a bad knee. It is pharmacology, not character.

Misuse is taking it in a way it was not prescribed: more, more often, or someone else's. Addiction, in clinical language an opioid use disorder, is the pattern of continuing despite harm: refills that run out early, a second prescriber, orders from overseas pharmacies, and a day organized around the bottle. The label calls tramadol "a substance with a high potential for abuse similar to other opioids" (section 9.2). The 2014 DEA rule rated its abuse potential as low relative to Schedule III drugs (Federal Register). Lower is not none, and the "it's only tramadol" belief is what lets a problem grow for years before anyone names it.

Signs tramadol has become a problem

The signs families describe to us most often look like this. The dose has crept up, or a month's prescription lasts two weeks. There is a low, irritable, achy feeling before the next tablet and a visible lift after it. Someone has started ordering online. There has been a seizure or a fainting spell nobody could explain. Sleep is bad and mood swings are worse. The person also takes an antidepressant, or drinks most nights, which raises the medical stakes. Any one of these is worth a conversation. Several together are worth a call.

Why stopping tramadol abruptly is risky

Opioid withdrawal is rarely fatal on its own. The danger sits in two other places. First, the label warns that "Rapid discontinuation of opioid analgesics has resulted in serious withdrawal symptoms, uncontrolled pain, and suicide," and instructs prescribers, "Do not abruptly discontinue ULTRAM in a patient physically dependent on opioids" (sections 2 and 5.17). Second, tolerance drops fast once someone stops, and this is the part that kills people. SAMHSA's overdose toolkit lists among its top risk factors "using drugs after a recent period of abstinence, which may decrease previous tolerance levels" (SAMHSA, 2023). A person who white-knuckles through a week of withdrawal and then goes back to the old dose is in more danger than before they quit.

Tramadol adds a risk other opioids do not. The label reports that "Seizures have been reported in patients receiving ULTRAM within the recommended dosage range," that the risk rises above that range, and that it rises further alongside SSRIs, tricyclic antidepressants, other opioids, MAO inhibitors, neuroleptics, or "other drugs that reduce the seizure threshold" (section 5).

Tramadol withdrawal timeline

Tramadol withdrawal has two parts. The first is ordinary opioid withdrawal. The label lists "restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, and mydriasis," then anxiety, aches, cramps, insomnia, nausea, vomiting, and diarrhea (section 9.3). The second comes from the serotonin and norepinephrine side. An earlier version of the Ultram label noted that withdrawal has "rarely" included hallucinations, and that "Other symptoms that have been reported less frequently with ULTRAM discontinuation include panic attacks, severe anxiety, and paresthesias" (Ultram prescribing information, 2008 revision). Paresthesias are the tingling and "brain zap" sensations anyone who has stopped an SSRI too fast will recognize. This is the general shape.

First 12 to 24 hours

With a half-life of six to seven hours, the first symptoms tend to arrive within a day: yawning, runny nose, sweating, restlessness, anxiety, and the sense that something is off. People on extended-release tablets may start a little later.

Days 2 to 4

Physical symptoms usually peak here: aches, stomach cramps, diarrhea, chills, insomnia. This is also when the atypical symptoms show up for some people: panic from nowhere, tingling or electric sensations, and, less often, hearing or seeing things that are not there. This is where "I'll just take one to get through the night" happens, which is why a plan for these exact nights matters more than resolve.

Days 5 to 10

The physical symptoms fade for most people. Mood, sleep, and energy are still poor, and cravings attach to the situations tramadol used to handle: pain flares, a stressful shift, the hour after the kids go to bed.

Weeks 2 and beyond

Low mood, anxiety, and broken sleep can hang on for weeks. Some people feel flatter than expected, and it can be hard to tell what is withdrawal, what is the original pain, and what is a depression the drug had been quietly treating.

How treatment works

For someone physically dependent on a prescribed dose, the label's guidance is a slow taper: "initiate the taper by a small enough increment, (e.g., no greater than 10% to 25% of the total daily dose) to avoid withdrawal symptoms, and proceed with dose-lowering at an interval of every 2 to 4 weeks." If symptoms appear, "it may be necessary to pause the taper for a period of time or raise the dose of the opioid analgesic to the previous dose, and then proceed with a slower taper" (section 2). For someone on 400 mg a day, the first step is 40 to 100 mg, and the whole process runs months.

For someone whose use has become an opioid use disorder, the standard of care is medication. SAMHSA's treatment protocol covers the three FDA-approved options, methadone, buprenorphine, and naltrexone, and states that they "reduce illicit opioid use, retain people in treatment, and reduce risk of opioid overdose death better than treatment with placebo or no medication" (SAMHSA TIP 63, Part 1). It is blunt about detox alone: "most patients with OUD who undergo medically supervised withdrawal will start using opioids again and won't continue in recommended care," and it says "Arbitrary time limits on the duration of treatment with OUD medication are inadvisable."

The label tells prescribers to "Discuss the availability of naloxone" with the patient and caregiver (section 2.2). Narcan 4 mg nasal spray has been sold over the counter since the FDA approved nonprescription use on March 29, 2023 (FDA). Keep it in the house.

Tramadol with alcohol, benzodiazepines, or antidepressants

The boxed warning states that "Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death" (boxed warning). Overdose deaths involving prescription opioids numbered 13,026 in 2023 (NIDA). The glass of wine or the Xanax at bedtime is not harmless.

The antidepressant interaction is specific to tramadol. The label warns that "Cases of serotonin syndrome, a potentially life-threatening condition, have been reported with the use of tramadol, particularly during concomitant use with serotonergic drugs," with symptoms that can include agitation, hallucinations, racing heart, fever, and rigidity (section 5). The DEA's fact sheet flags the same risk with MAO inhibitors and SSRIs (DEA), and many people who misuse tramadol are on an SSRI.

Drug testing for tramadol

The standard "opiates" line on most drug panels will not catch tramadol. The American College of Medical Toxicology's practice statement says that "Separate assays are required to reliably detect buprenorphine, fentanyl, fentanyl analogs, hydrocodone, methadone, compounds in kratom, tramadol, oxycodone, U-47700, or other semisynthetic or synthetic opioids" (ACMT, 2021). A clean five-panel test from work says nothing about tramadol; whoever orders testing needs to ask for a tramadol-specific assay.

How long it stays detectable depends on dose, duration of use, and the lab's cutoff. With half-lives of roughly six to seven hours for the drug and its metabolite (prescribing information, section 12.3), most of a single dose is gone within a couple of days; months of daily use extends that. We would rather not quote one number, because it depends on the assay. A prescribed, tapering dose will test positive; what matters is whether the result matches the plan.

Our members use saliva-based screening that is assigned at random through the week. You do not choose whether you test; you choose who sees the results. For most members that means the prescriber and, if they want, a spouse or parent. We explain the details in our guide to how sobriety monitoring works.

How recovery from tramadol works with Accountable

We are not a detox and we do not prescribe. The taper or the buprenorphine belongs to your doctor. What we provide is the support around it, at home, for as long as you need it.

1. Get the full picture

In the first sessions your coach maps what is actually going on: how much, for how long, where the pills come from, whether there has ever been a seizure, and what else is in the picture, including antidepressants, alcohol, and the pain that started all this. If you do not yet have a prescriber managing a taper or medication for opioid use disorder, we help you find one, and with your permission we coordinate so everyone works from the same plan.

2. Build a plan that fits your life

A plan that only works if you take three weeks off is a plan you will abandon. Your coach helps you plan around the real calendar: which nights the panic tends to hit, what you will do about a pain flare that is not an emergency, who you will text before you call the old contact. Daily peer group meetings and a weekly family Zoom group give the people around you their own place to get support.

3. Weekly check-ins through the long stretch

The flat, anxious weeks after tramadol are where people quietly give up. Your coach shows up every week, and the saliva screening turns "I think he's doing okay" into a shared record that you control. When a slip happens, we treat it as information. The plan changes and the support goes up, and because tolerance drops so quickly, we make sure naloxone is in the house. Every coach at Accountable has their own recovery behind them, and many have been through opioids specifically.

Accountable is covered by a growing list of commercial health plans, with more added each month, and private-pay plans start at $375 per month. You can check your coverage in a few minutes or call the care team at (646) 450-7641. Families are welcome to make the first call; see our page for families.

Common questions

Is tramadol actually an opioid?

Yes. It binds to the same mu-opioid receptors as other opioids, carries the same boxed warnings, and has been a Schedule IV controlled substance since August 18, 2014 (Federal Register). It also affects serotonin and norepinephrine, which is why it feels different from hydrocodone and why withdrawal can include panic and tingling.

Can you become dependent on tramadol if you take it as prescribed?

Yes. The label describes physical dependence as the body adapting "after a period of regular exposure," with withdrawal following abrupt discontinuation or a significant dose reduction (section 9.3). Dependence is expected with steady use. It is not the same as addiction, and it does not mean you did anything wrong.

How long does tramadol withdrawal last?

Physical symptoms usually start within a day, peak around days two to four, and ease over a week to ten days. Mood, sleep, and anxiety can take weeks longer. A taper of 10 to 25 percent every two to four weeks, as the label recommends, keeps most of this mild (section 2).

Does tramadol show up on a drug test?

Not on a standard opiate screen. Tramadol needs its own assay (ACMT). If a test is meant to check for tramadol, confirm that it is on the panel.

What should I do if someone on tramadol will not wake up?

Call 911, give naloxone if you have it, and stay with them on their side. Naloxone "rapidly reverses the effects of opioid overdose" (FDA) and does no harm if opioids turn out not to be involved (SAMHSA). It can wear off before the tramadol does, so they still need emergency care.

Sources

• U.S. Food and Drug Administration. Ultram (tramadol hydrochloride) tablets, prescribing information, revised February 2023.

• U.S. Food and Drug Administration. Ultram (tramadol hydrochloride) tablets, prescribing information, revised April 2019 (section 12.3, pharmacokinetics).

• U.S. Food and Drug Administration. Ultram (tramadol hydrochloride) tablets, prescribing information, revised March 2008 (Warnings, withdrawal).

• Drug Enforcement Administration. Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV. Federal Register, final rule, July 2, 2014.

• Drug Enforcement Administration, Diversion Control Division. Tramadol, drug and chemical information sheet, May 2026.

• Drug Enforcement Administration. One Pill Can Kill, Get Smart About Drugs.

• Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder, Part 1: Introduction to Medications for Opioid Use Disorder Treatment. 2021 update, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. Overdose Prevention and Response Toolkit. PEP23-03-00-001, 2023.

• U.S. Food and Drug Administration. FDA Approves First Over-the-Counter Naloxone Nasal Spray. Press announcement, March 29, 2023.

• National Institute on Drug Abuse. Drug Overdose Deaths: Facts and Figures.

• Stolbach AI, Connors NJ, Nelson LS, Kulig K. ACMT Practice Statement: Interpretation of Urine Opiate and Opioid Tests. American College of Medical Toxicology, September 13, 2021.